GlaxoSmithKline teams up with F1's McLaren
British drugmaker GlaxoSmithKline announced on Thursday a research and development partnership with Formula One giant McLaren Group.
Under a five-year agreement, McLaren will share its engineering knowledge "to help deliver world class performance across GSK's global businesses," a statement said.
A learning facility, the McLaren GSK Centre for Applied Performance, focused on developing British engineering skills and processes, will be built at McLaren's Headquarters in Woking, close to London, and open for business in 2013.
"Employees from both organisations and business partners will be able to use the facility to share ideas and collaborate on joint working projects," GSK said.
GSK chief excutive Andrew Witty said the partnership "brings together two British companies whose continued success hinges on the ability to innovate and rapidly respond to change and competitor activity."
Ron Dennis, executive chairman of McLaren Group and McLaren Automotive, said he hoped that GSK would "harness McLaren's world-beating Formula 1-bred technology, processes and operational dynamism."
© 2011 AFP